# Texas Donor Network – FDA Inspection, Sep 2, 2026

Source: https://www.keypedia.com/records/fda_inspections/texas-donor-network/a57229f0-a80e-41d1-96bd-874885041133
Source feed: FDA_Inspections

> FDA inspection 1333974 of Texas Donor Network, September 02, 2026. 2 citations under 21 CFR part 1271. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1333974
- Company Name: Texas Donor Network
- Inspection Date: 2026-09-02
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Dallas District Office
- Citation Count: 2

## Related Documents

- [FDA Inspection 1075469 - 2018-12-14](https://www.keypedia.com/records/fda_inspections/texas-donor-network/e4c028f4-a7ef-44c2-9df0-01ee2695c733)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/elyshia-q-danaher/73046c15-abb1-431e-8a76-59c7e8c1604a)

Company: https://www.keypedia.com/companies/texas-donor-network/d4496724-5a89-4dd3-b3fd-4ff5885c9752

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9